Jacques Banchereau

Jacques Banchereau is the current Chief Science Officer at Immunai. Prior to this, they were a Professor of Clinical Immunology at Université Paris 13 from January 2014 to October 2021. Before that, they worked at The Jackson Laboratory, Icahn School of Medicine at Mount Sinai, Baylor College Of Dentistry, and Baylor University.

Jacques Banchereau was educated at the Université Claude Bernard Lyon 1, where they earned their Doctor of Philosophy (PhD) in HDR "Habilitation a diriger des recherches." Jacques also holds a Doctor of Philosophy (PhD) in Biochemistry from the University of Paris I: Panthéon-Sorbonne. Jacques began their educational career with a Bachelor of Science (BS) in Pharmacy from the Université d'Angers.

Some individuals on their team include Peter Smibert - VP, Functional Genomics, Marisa Mariani - Senior Scientist, and Tali Raveh-Sadka - Director of Computational Biology. Their manager is Noam Solomon, Co-Founder & CEO. They are on a team with Gail Katz - VP, Intellectual Property Strategy, Luis Voloch - Co-Founder & CTO, and Evan Zisholtz - VP, Corporate Development.